INDV Indivior Pharmaceuticals, Inc.

Fundamentals / CIK 0001625297 / USD
Other share classes on CIK 0001625297: SUPN

Indivior Pharmaceuticals, Inc. reported $1.37B in revenue and net income of $450.0M for the trailing twelve months ended September 30, 2026 (up 13.4% year over year), with a 85.0% gross margin and a 40.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INDV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$1.23B$617.2M$0-$223.1MFY 2021 Revenue: $791.0MFY 2021 Net Income: $205.0M2021FY 2022 Revenue: $901.0MFY 2022 Net Income: -$42.00M2022FY 2023 Revenue: $1.09BFY 2023 Net Income: -$126.0M2023FY 2024 Revenue: $1.19BFY 2024 Net Income: $7.00M2024FY 2025 Revenue: $1.24BFY 2025 Net Income: $210.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.24B $1.19B $1.09B $901.0M $791.0M
Cost of Revenue $246.0M $231.0M $174.0M $151.0M $127.0M
Gross Profit $994.0M $957.0M $919.0M $749.0M $664.0M
Research & Development $97.00M $107.0M $116.0M $74.00M $52.00M
Selling, General & Admin $634.0M $612.0M $565.0M $466.0M $431.0M
Total Operating Expenses -- $919.0M $1.07B $827.0M --
Operating Income $262.0M $38.00M -$152.0M -$77.00M $213.0M
EBITDA $272.0M $54.00M -$137.0M -$61.00M $228.0M
Interest Income $22.00M $23.00M $43.00M $19.00M $4.00M
Interest Expense $45.00M $41.00M $35.00M $27.00M $27.00M
Income Before Tax $239.0M $20.00M -$145.0M -$86.00M $190.0M
Income Tax Expense $29.00M $13.00M -$19.00M -$43.00M -$15.00M
Net Income $210.0M $7.00M -$126.0M -$42.00M $205.0M
Basic EPS $1.68 $0.05 -$0.92 -$0.30 $7.05
Diluted EPS $1.64 $0.05 -$0.92 -$0.30 $6.75
Basic Shares Outstanding 125.0M 132.0M 137.0M 139.0M 29.1M
Diluted Shares Outstanding 128.0M 133.0M 137.0M 139.0M 30.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $356.0M $343.0M $317.0M $358.0M $314.0M $302.0M $266.0M $299.0M
Cost of Revenue $51.00M $50.00M $40.00M $67.00M $83.00M $52.00M $44.00M $48.00M
Gross Profit $305.0M $294.0M $277.0M $292.0M $230.0M $250.0M $221.0M $250.0M
Research & Development $5.00M $12.00M $16.00M $21.00M $33.00M $21.00M $22.00M $31.00M
Selling, General & Admin $119.0M $122.0M $124.0M $189.0M $154.0M $158.0M $133.0M $175.0M
Total Operating Expenses $125.0M $134.0M $139.0M -- $187.0M $179.0M $156.0M $205.0M
Operating Income $180.0M $160.0M $137.0M $81.00M $43.00M $72.00M $66.00M $46.00M
EBITDA $181.0M $162.0M $139.0M $83.00M $46.00M $74.00M $69.00M $51.00M
Interest Income $4.00M $3.00M $3.00M $6.00M $6.00M $6.00M $4.00M $5.00M
Interest Expense $2.00M $2.00M $7.00M $6.00M $12.00M $15.00M $12.00M $13.00M
Income Before Tax $182.0M $160.0M $115.0M $81.00M $37.00M $62.00M $59.00M $38.00M
Income Tax Expense $45.00M $38.00M $26.00M -$21.00M -$5.00M $44.00M $11.00M $17.00M
Net Income $137.0M $122.0M $89.00M $102.0M $42.00M $18.00M $47.00M $21.00M
Basic EPS $1.16 $1.02 $0.71 -- $0.34 $0.15 $0.38 --
Diluted EPS $1.12 $0.98 $0.69 -- $0.33 $0.14 $0.38 --
Basic Shares Outstanding 118.0M 119.0M 124.0M -- 125.0M 125.0M 124.0M --
Diluted Shares Outstanding 122.0M 124.0M 129.0M -- 129.0M 126.0M 125.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $195.0M $319.0M $316.0M $774.0M $1.10B
Short-Term Investments $0 $1.00M $94.00M -- --
Cash & Short-Term Investments $195.0M $320.0M $410.0M $774.0M $1.10B
Accounts Receivable, Net $253.0M $254.0M $254.0M $220.0M $202.0M
Inventory $153.0M $167.0M $126.0M $114.0M $95.00M
Other Current Assets $16.00M $21.00M $457.0M $27.00M $32.00M
Total Current Assets $652.0M $827.0M $1.26B $1.26B $1.44B
Property, Plant & Equipment, Net $144.0M $100.0M $84.00M $54.00M $58.00M
Goodwill $2.00M $2.00M $5.00M -- --
Long-Term Investments $28.00M $27.00M $41.00M -- --
Other Non-Current Assets $27.00M $39.00M $36.00M $38.00M $106.0M
Total Non-Current Assets $549.0M $489.0M $691.0M $510.0M $388.0M
Total Assets $1.20B $1.32B $1.76B $1.77B $1.83B
Accounts Payable $48.00M $63.00M $39.00M $33.00M $26.00M
Short-Term Debt $29.00M $18.00M $3.00M $3.00M $3.00M
Other Current Liabilities $0 $11.00M $40.00M $79.00M $61.00M
Total Current Liabilities $914.0M $924.0M $1.28B $1.02B $804.0M
Long-Term Debt $290.0M $315.0M $237.0M $237.0M $239.0M
Other Non-Current Liabilities $21.00M $18.00M $31.00M $428.0M $474.0M
Total Non-Current Liabilities $386.0M $728.0M $649.0M $699.0M $825.0M
Total Liabilities $1.30B $1.65B $1.94B $1.72B $1.63B
Total Debt (incl. Leases) $351.0M $375.0M $354.0M $361.0M $360.0M
Common Stock $62.00M $62.00M $68.00M $68.00M $70.00M
Retained Earnings -$243.0M -$443.0M -$288.0M $1.30B $1.44B
Accumulated Other Comp. Income -$30.00M -$36.00M -$30.00M -$1.29B -$1.29B
Total Stockholders' Equity -$98.00M -$337.0M -$184.0M -$15.00M $121.0M
Total Equity -$98.00M -$337.0M -$184.0M -$15.00M $121.0M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $305.0M $222.0M $175.0M $195.0M $445.0M $510.0M $372.0M $319.0M
Short-Term Investments -- -- -- $0 $0 $0 $1.00M $1.00M
Cash & Short-Term Investments $305.0M $222.0M $175.0M $195.0M $445.0M $510.0M $373.0M $320.0M
Accounts Receivable, Net $273.0M $271.0M $273.0M $253.0M $259.0M $240.0M $243.0M $254.0M
Inventory $149.0M $150.0M $152.0M $153.0M $155.0M $149.0M $163.0M $167.0M
Other Current Assets $40.00M $54.00M $40.00M $16.00M $19.00M $20.00M $20.00M $21.00M
Total Current Assets $800.0M $725.0M $667.0M $652.0M $922.0M $951.0M $883.0M $827.0M
Property, Plant & Equipment, Net $175.0M $162.0M $157.0M $144.0M $124.0M $117.0M $104.0M $100.0M
Goodwill -- -- -- $2.00M -- -- -- $2.00M
Long-Term Investments $27.00M $27.00M $27.00M $28.00M $28.00M $27.00M $27.00M $27.00M
Other Non-Current Assets $27.00M $24.00M $26.00M $27.00M $27.00M $44.00M $39.00M $39.00M
Total Non-Current Assets $532.0M $508.0M $530.0M $549.0M $494.0M $501.0M $492.0M $489.0M
Total Assets $1.33B $1.23B $1.20B $1.20B $1.42B $1.45B $1.38B $1.32B
Accounts Payable $28.00M $30.00M $35.00M $48.00M $41.00M $50.00M $46.00M $63.00M
Short-Term Debt $488.0M $0 $0 $29.00M $18.00M $18.00M $18.00M $18.00M
Other Current Liabilities -- -- -- $0 $0 $0 $3.00M $11.00M
Total Current Liabilities $1.30B $868.0M $779.0M $914.0M $965.0M $1.06B $1.00B $924.0M
Long-Term Debt $0 $487.0M $486.0M $290.0M $304.0M $308.0M $311.0M $315.0M
Other Non-Current Liabilities $42.00M $31.00M $21.00M $21.00M $30.00M $18.00M $17.00M $18.00M
Total Non-Current Liabilities $91.00M $573.0M $562.0M $386.0M $658.0M $653.0M $655.0M $728.0M
Total Liabilities $1.39B $1.44B $1.34B $1.30B $1.62B $1.71B $1.66B $1.65B
Total Debt (incl. Leases) $501.0M $509.0M $509.0M $351.0M $356.0M $366.0M $370.0M $375.0M
Common Stock $0 $0 $0 $62.00M $62.00M $62.00M $62.00M $62.00M
Retained Earnings -$197.0M -$334.0M -$280.0M -$243.0M -$346.0M -$388.0M -$406.0M -$443.0M
Accumulated Other Comp. Income -$26.00M -$28.00M -$29.00M -$30.00M -$32.00M -$33.00M -$35.00M -$36.00M
Total Stockholders' Equity -$60.00M -$208.0M -$144.0M -$98.00M -$207.0M -$257.0M -$285.0M -$337.0M
Total Equity -$60.00M -$208.0M -$144.0M -$98.00M -$207.0M -$257.0M -$285.0M -$337.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $210.0M $7.00M -$126.0M -$42.00M $205.0M
Depreciation & Amortization $10.00M $16.00M $15.00M $16.00M $15.00M
Stock-Based Compensation $26.00M $24.00M $21.00M $16.00M $11.00M
Change in Receivables $3.00M -$1.00M -$33.00M -$21.00M -$25.00M
Change in Inventory $18.00M -$43.00M -$6.00M -$30.00M -$3.00M
Operating Cash Flow -$27.00M $36.00M -$300.0M -$4.00M $353.0M
Capital Expenditure -$66.00M -$29.00M -$8.00M -$5.00M -$4.00M
Free Cash Flow -$93.00M $7.00M -$308.0M -$9.00M $349.0M
Acquisitions, Net $0 $0 -$129.0M $0 $0
Investing Cash Flow -$66.00M $69.00M -$95.00M -$222.0M -$14.00M
Common Stock Issued $2.00M $3.00M $3.00M $2.00M --
Share Repurchases -$11.00M -$173.0M -$33.00M -$90.00M -$101.0M
Financing Cash Flow -$30.00M -$102.0M -$64.00M -$101.0M -$94.00M
Net Change in Cash -$124.0M $3.00M -$459.0M -$327.0M $244.0M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $137.0M $122.0M $89.00M $102.0M $42.00M $18.00M $47.00M $21.00M
Depreciation & Amortization $1.00M $2.00M $2.00M $2.00M $3.00M $2.00M $3.00M $5.00M
Stock-Based Compensation $8.00M $11.00M $9.00M $5.00M $7.00M $8.00M $6.00M $6.00M
Change in Receivables -$2.00M $3.00M -$20.00M $6.00M -$18.00M $4.00M $11.00M -$4.00M
Change in Inventory $1.00M $4.00M -$1.00M $2.00M -$6.00M $17.00M $5.00M -$2.00M
Operating Cash Flow $97.00M $229.0M -$9.00M -$221.0M -$39.00M $158.0M $75.00M -$17.00M
Capital Expenditure -$14.00M -$7.00M -$20.00M -$24.00M -$20.00M -$17.00M -$5.00M -$16.00M
Free Cash Flow $83.00M $222.0M -$29.00M -$245.0M -$59.00M $141.0M $70.00M -$33.00M
Investing Cash Flow -$14.00M -$8.00M -$19.00M -$24.00M -$20.00M -$17.00M -$5.00M $8.00M
Common Stock Issued $0 $0 $0 $0 $1.00M $0 $1.00M $0
Share Repurchases $0 -$177.0M -$125.0M $0 $0 $0 -$11.00M -$50.00M
Financing Cash Flow $0 -$173.0M $7.00M -$5.00M -$3.00M -$5.00M -$17.00M $40.00M
Net Change in Cash $82.00M $48.00M -$20.00M -$252.0M -$61.00M $136.0M $53.00M --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 80.2% 80.6% 84.1% 83.1% 83.9%
Operating Margin 21.1% 3.2% -13.9% -8.5% 26.9%
Net Profit Margin 16.9% 0.6% -11.5% -4.7% 25.9%
Return on Equity (ROE) -- -- -- -- 169.4%
Return on Assets (ROA) 17.5% 0.5% -7.2% -2.4% 11.2%
Current Ratio 0.71x 0.90x 0.98x 1.24x 1.80x
Quick Ratio 0.55x 0.71x 0.88x 1.12x 1.68x
Debt to Equity -- -- -- -- 2.98x
Revenue Growth (YoY) +4.3% +8.7% +21.3% +13.9% --
Gross Profit Growth (YoY) +3.9% +4.1% +22.7% +12.8% --
Operating Income Growth (YoY) +589.5% -- -- -136.2% --
Net Income Growth (YoY) +2900.0% -- -- -120.5% --
EPS Growth (YoY) +3260.0% -- -- -104.3% --
Operating Cash Flow Growth (YoY) -175.0% -- -- -101.1% --
Free Cash Flow Growth (YoY) -1428.6% -- -- -102.6% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 85.0% 82.1% 81.3% 80.1% 80.5% 81.9% 79.6% 80.5%
Operating Margin 40.6% 31.6% 25.8% 21.1% 19.2% 18.7% 2.5% 3.2%
Net Profit Margin 32.8% 26.7% 19.4% 16.9% 10.8% 9.2% -0.6% 0.6%
Return on Assets (ROA) 33.8% 28.8% 21.0% 17.4% 9.0% 7.4% -0.5% 0.5%
Current Ratio 0.61x 0.84x 0.86x 0.71x 0.96x 0.90x 0.88x 0.90x
Quick Ratio 0.50x 0.66x 0.66x 0.55x 0.79x 0.76x 0.72x 0.71x
Revenue Growth (YoY) +13.4% +13.6% +19.2% +19.7% +2.3% +1.0% -6.3% --
Gross Profit Growth (YoY) +32.6% +17.6% +25.3% +16.8% -4.6% +13.6% -10.2% --
Operating Income Growth (YoY) +318.6% +122.2% +107.6% +76.1% +22.9% -- -12.0% --
Net Income Growth (YoY) +226.2% +577.8% +89.4% +385.7% +90.9% -- -23.0% --
EPS Growth (YoY) +241.2% +580.0% +86.8% -- +112.5% -- -15.6% --
Operating Cash Flow Growth (YoY) -- +44.9% -112.0% -- -2050.0% +79.5% -- --
Free Cash Flow Growth (YoY) -- +57.4% -141.4% -- -- +67.9% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001625297) · from December 31, 2021 Data through September 30, 2026 · synced Nov 20, 2026, 05:17 UTC · Open in terminal